➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Dow
Johnson and Johnson
Mallinckrodt
McKinsey

Last Updated: October 18, 2021

DrugPatentWatch Database Preview

Formulation information for generic ingredient: efinaconazole


Email this page to a colleague

« Back to Dashboard

Efinaconazole

CASRN: 164650-44-6

Manufacturing Methods

<truncated in preview>

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Express Scripts
Johnson and Johnson
Baxter
Boehringer Ingelheim
AstraZeneca